Cyclosporin A and PSC 833 prevent up-regulation of MDR1 expression by anthracyclines in a human multidrug-resistant cell line

Clinical Cancer Research

Volumn 2, Issue 4, 1996, Pages 713-720

  Hu, Xiu F ^a   Slater, Alison ^a   Wall, Dominic M ^a   Parkin, John D ^a   Kantharidis, Phillip ^a   Zalcberg, John R ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DAUNORUBICIN; EPIRUBICIN; GLYCOPROTEIN P; VALSPODAR;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PREVENTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; CYCLOSPORINE; CYCLOSPORINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EPIRUBICIN; HUMANS; P-GLYCOPROTEIN; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0029866650     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Rothenberg, M., Mickley, L. A., Cole, D. E., Balis, F. M., Tsuruo, T., Poplack, D., and Fojo, A. T. Expression of the MDR1/P-170 gene in patients with acute lymphoblastic leukemia. Blood. 74: 1388-1395, 1989.
2. Deuchars, K. L., and Ling, V. P-glycoprotein and multidrug resistance in cancer chemotherapy. Semm. Oncol., 16: 156-165, 1989.
3. Goldstein, L. J., Pastan, P., and Gottesman, M. M. Multidrug resistance in human cancer. Crit. Rev. Oncol. Hematol., 12: 243-253, 1992.
4. Nooter, K., and Sonneveld, P. Clinical relevance of P-glycoprotein expression in haematological malignancies (Review). Leuk. Res., 18: 233-243, 1994
5. Campos, L., Guyotat, D., Archmbaud, E., Calmard-Oriol, P., Tsuruo T., Troncy, J., Treille D., and Fiere D. Clinical significance of multidrug resistance and P-glycoprotein expression on acute non-lymphoblastic leukemia cells at diagnosis. Blood. 79: 473-476, 1992.
6. Shen, D-W., Fojo, A., Chin, J. E., Roninson, T. B., Riehert, N., Pastan, I , and Gottesman, M M. Human multidrug-resistant cell lines: increased MDR1 expression can precede gene amplification. Science (Washington DC), 232: 643-645, 1986
7. Gasgune, J. E., Dossot, J-M., Fardel O., Le Mee F., Le Gall, E., Leblay, R., LePrise, P. Y., Chaperon, J , and Fauchet, R. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia; prognostic implications. Blood. 81: 2394-2398, 1993.
8. Hu, X. F., Slater, S., Wall, D. M., Kamharidis, P, Parkin, J. D , Cowman, A., and Zalcberg, J. R. Rapid upregulation of MDR1 expression by anthracyclines in a classical mullidrug-resistant cell line. Br. J. Cancer, 71: 931-936, 1995.
9. Ford, J. M., and Hait, W. N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev., 42: 156-199, 1990.
10. Slater, L M., Sweet, P., Stupecky, M., Welzel, M W., and Gupta, S. Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma. Br. J. Cancer. 54: 235-238, 1986.
11. Twentyman, P. R., and Bleehan, N. H. Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A. Eur. J. Cancer, 27: 1639-1642, 1991.
12. Twentyman, P. R. Cyclosporins as drug resistance modifiers. Biochem. Pharmacol., 43: 109-117, 1992.
13. Safa, A. R. Photoaffinity labeling of the multidrug-resistance related P-glycoprotein with photoactive analogs of verapamil. Proc. Natl. Acad. Sci. USA, 85: 7187-7191, 1988.
14. Yusa, K., and Tsuruo, T. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res., 49: 5002-5006, 1989.
15. Goldberg, H., Ling, V., Wong, P. Y., and Skorecki, K. Reduced cyclosporin accumulation in multidrug-resistant cells. Biochem. Biophys. Res. Commun., 152: 552-558, 1988.
16. Foxwell, B. M. J., Mackie, A., Ling, V., and Ryffel, B. Identification of the multidrug resistance-related P-glycoprotein as a cyclosporin binding protein. Mol. Pharmacol., 36: 543-546, 1989.
17. Emmel, E. A., Verweij, C. L., Durand, D. B., Higgins, K. M., Lacy, E., and Crabtree, G, R. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science (Washington DC), 246: 1617-1620, 1989.
18. Zalcberg, J. R., Hu, X F., Wall, D. M., Mirski, S., Cole, S., Nadalin, G., de Luise, M., Parkin, J. D., Vrazas, V., Campbell, L., and Kantharidis. P, Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line. Int. J. Cancer, 57: 522-528, 1994.
19. Foley, G. E., Lazarus, H., Farber, S., Uzman, B. G., Boone, B. A., and McCarthy, R. E. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer (Phila.), 18: 522-529, 1965.
20. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
21. Ueda, K., Clark, D. P., Chen, C.-J., Roninson, I. B., Gortesman, M. M., and Pastan, I. The human multidrug resistance (MDR1) gene: cDNA cloning and transcription initiation. J. Biol. Chem., 262: 505-508, 1987.
22. Hu, X. F., De Luise, M., Martin, T. J., and Zalcberg, J. R. Effect of cyclosporin and verapamil on the cellular kinetics of daunorubicin. Eur. J. Cancer, 26, 814-817, 1990.
23. Tsuruo, T., Iida, H., Tsukagoshi, S., and Sakurai, Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res., 41: 1967-1972, 1981
24. Hu, X. F., Martin, T. J., Bell, D. R., de Luise, M., and Zalcberg, J. R. Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines. Cancer Res., 50: 2953-2957, 1990.
25. Chin, K. V., Chauhan, S. S., Pastan, I., and Gottesman, M. M. Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells. Cell Growth & Differ., 1. 361-365, 1990.
26. Chin, K. V., Tanaka, S., Darlington, G., Pastan, I., and Gottesman, M. M. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem., 205: 221-226, 1990.
27. Kioka, N., Yamano, Y., Komano, T., and Ueda, K. Heat-shock responsive elements in the induction of multidrug resistance gene (MDR 1). FEBS Lett., 301: 37-40, 1992.
28. Chaudhary, P. M., and Roninson I. B. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C. Oncol. Res., 4: 281-290, 1992.
29. Bates, S. E., Lee, J. S., Dickstein, B., Spolyar, M., and Fojo, A. T. Differential modulation of P-glycoprotein transport by protein kinase inhibition. Biochemistry, 32: 9156-9164, 1993.
30. Mickley, L. A., Bates, S. E., Richert, N. D., Currier, S., Tanaka, S., Fos, F., Rosen, N., and Fojo, A. T. Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents. J. Biol. Chem., 264: 18031-18040, 1989.
31. Chaudhary, P. M., and Roninson, I. B. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs J. Natl Cancer Inst., 85: 632-639, 1993.
32. Kioda, N., Hosokawa, N., Komano, T., Hirayoshi, K., Nagata, K., and Ueda, K. Quercetin, a bioflavonoid, inhibits the increase of human multidrug resistance gene (MDR1) expression caused by arsenite. FEBS Lett., 301. 307-309, 1992.
33. Flanagan, W. M., Corthesy, B., Bram, R. J., and Crabtree, G. R. Nuclear association of T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature (Lond.), 352: 803-807, 1991.
34. Jain, J., McCaffrey, P. G., Valge-Acher, V. E., and Rao, A. Nuclear factor of activated T cells contains fos and jun. Nature (Lond.). 356: 801-804, 1992.
35. McCaffrey, P. G., Luo, C., Kerppola, T. K., Jain, J., Badalian, T. M., Ho, A. M., Burgeon, E., Lane, W. S., Lambert, J N., Curran, T., Verdine, G. L., Rao, A., and Hogan, P. G. Isolation of cyclosporin-sensitive T cell transcription factor NFATp. Science (Washinston DC), 262: 750-754, 1993.
36. Cockerill, P. N., Shannon, F., Bert, A. G., Ryan, G. R., and Vadas, M. A The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc. Natl. Acad. Sci. USA. 90: 2466-2470, 1993.
37. Szabo, S. J., Gold, J. S., Murphy, T. L., and Murphy, K. M. identification of cis-acting regulatory elements controlling mterleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc. Mol. Cell Biol., 13: 4793-4805, 1993.
38. Nair, A. P. K., Hahn, S., Banholzer, R.., Hirsch, H. H., and Moroni, C. Cyclosporin A inhibits, growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA. Nature (Lond.), 369: 239-242, 1994.